The breast cancer diagnosis shook my dreams and goals. The thought of not seeing my son growing up filled me with sadness and fear. I had to stay alive. It was important to make the right decision on the treatment(s) I was going to follow.
The doctor who did the excision biopsy told me that surgery, chemotherapy and radiation were my only options. She said I could possibly live another 5 years if I refuse the treatment. However when I asked her how long l will live by doing the orthodox treatment, she could only guarantee me 5 years of life.
It felt like a death sentence was spoken over me.
The first decision I had to make was to choose between the orthodox treatment of surgery followed by chemotherapy and radiation or an alternative treatment to kill the cancer cells.
This wasn’t an easy choice to make. I researched both options and in the end, I chose the alternative.
Why I didn’t choose the Conventional Chemotherapy and Radiation Protocol :
My reasons were that I’ve seen that most women undergoing the orthodox treatments suffered severe side effects during and after the treatments. Many still died shortly afterwards.
Chemotherapy destroys cancer cells because the medicines target rapidly dividing cells. But normal cells in your blood, mouth, intestinal tract, nose, nails, vagina, and hair also divide rapidly. So chemotherapy affects them as well.
The American Cancer Society listed the “Possible side effects of chemo for breast cancer” as follows:
“Some of the most common possible side effects include:
- Hair loss
- Nail changes
- Mouth sores
- Loss of appetite or increased appetite
- Nausea and vomiting
Chemo can affect the blood-forming cells of the bone marrow, which can lead to:
- Increased chance of infections (from low white blood cell counts)
- Easy bruising or bleeding (from low blood platelet counts)
- Fatigue (from low red blood cell counts and other reasons)
Other side effects are also possible.
- Nerve damage (neuropathy)
- Hand-foot syndrome
- Chemo brain
- Feeling unwell or tired (fatigue)
- Heart damage
- Menstrual changes and fertility issues
- Increased risk of leukemia
Many drugs used to treat breast cancer, including the taxanes (docetaxel and paclitaxel), platinum agents (carboplatin, cisplatin), vinorelbine, eribulin, and ixabepilone, can damage nerves outside of the brain and spinal cord. This can sometimes lead to symptoms (mainly in the hands and feet) of numbness, pain, burning or tingling sensations, sensitivity to cold or heat, or weakness. In most cases this goes away once treatment is stopped, but it might last a long time in some women.
Many women who are treated for breast cancer report a slight decrease in mental functioning. They may have some problems with concentration and memory.
You can also have sleep problems and sometimes women become depressed.
Doxorubicin, epirubicin, and some other chemo drugs may cause permanent heart damage (called cardiomyopathy).
For younger women, changes in menstrual periods are a common side effect of chemo. Premature menopause and infertility (not being able to become pregnant) may occur and may be permanent.
Very rarely, but certain chemo drugs can cause diseases of the bone marrow, such as myelodysplastic syndrome or even acute myeloid leukemia, a cancer of white blood cells. ”
You can go and read more about the side effects on the American Cancer Society website: www.cancer.org/cancer/breast-cancer/treatment/chemotherapy-for-breast-cancer.html
Reasons for choosing the Alternative Protocol of High
Dose Intravenous Vitamin C:
I was familiar with the positive results (with minimal or no side effects) that could be achieved with high dose intravenous vitamin C drips (IVC) on cancer.
Suret Morkel (Microbiologist , Medical Scientist , Natural Practitioner and friend), had been using Vitamin C (IVC) at her practice and experienced good results over many years. This information together with my own research encouraged me to choose Vitamin C (IVC) as one of the main therapies to fight the cancer.
A brief Historical Background of High-dose Vitamin C Therapy from the International Journal of Cancer Research: http://ar.iiarjournals.org/content/29/3/809.full
“Vitamin C (ascorbate) is one of the early unorthodox therapies for cancer, based on two hypotheses but without supporting data. Nearly 50 years ago, McCormick postulated that ascorbate protects against cancer by increasing collagen synthesis. In 1972, Cameron and Rotman hypothesized that ascorbate could have anti-cancer action by inhibiting hyaluronidase and thereby preventing cancer spread. These hypotheses were subsequently popularized by Cameron and Pauling. Cameron and Campbell initially published case reports of 50 patients, some of whom have benefited from high-dose intravenous (IVC) ascorbate treatment.
Unfortunately, two randomized clinical trials with oral ascorbate alone, which does not comply with the dosages achieved by intravenous adminstration, conducted by the Mayo clinic showed no benefit (Creagan, et al., 1979; Moertel, et al., 1985). This brought Vitamin C in question as a suitable treatment for cancer.
Vitamin C can be safely administered by intravenous infusion (IVC) at maximum doses of one-hundred grams or less, provided the precautions outlined in this Riordan report are taken.
There are several potential benefits to giving IVC to cancer patients:
- Cancer patients are often depleted of vitamin C, and IVC provides an efficient means of restoring tissue stores.
- IVC has been shown to improve quality of life in cancer patients.
- IVC reduces inflammation (as measured by c-reactive protein levels) and reduces the production of pro-inflammatory cytokines.
- At high concentrations, ascorbate is preferentially toxic to tumor cells and is an angiogenesis inhibitor.”
“The Riordan Clinic has treated hundreds of cancer patients (Figure 1) using the Riordan protocol. At the same time, Riordan Clinic Research Institute (RCRI) has been researching the potential of intravenous vitamin C therapy for over thirty years. Their efforts have included in vitro studies, animal studies, pharmacokinetic analyses, and clinical trials.
The Riordan IVC Protocol for Adjunctive Cancer Care Intravenous Ascorbate as a Chemotherapeutic and Biological Response Modifying Agent clinical trial concluded that:
“Vitamin C can accumulate in tumors, with significant tumor growth inhibition seen (in guinea pigs) at intra-tumor concentrations of 1 mM or higher.”
You can find more about the Riordan report and protocol of actual dosage at : http://www.doctoryourself.com/riordan1.html
Another recent study of “Breast Cancer Patients’ Treatment Choices and Outcomes in a Naturopathic Clinic” published in the International Journal of Cancer Research & Therapy authored by Colleen Huber, NMD, FNORI Fellow, Naturopathic Oncology Research Institute, USA.
“Our clinic conducted a survey by questionnaire to breast cancer patients who had in common the following: a biopsy-diagnosed breast cancer, Stage I through late Stage IV, and that they stayed in our care for at least 4 treatments of IV nutrient infusions. Those treatments involved sterile infusions of primarily, by volume and osmolarity, high-dose intravenous vitamin C (HDIVC), which has been studied in numerous venues for anti-cancer effect.
Oral dosing of ascorbic acid has not been found to achieve sufficiently high concentrations in the vascular system to kill cancer cells. However, intravenous use of ascorbic acid rose to plasma concentrations that were associated with apoptosis of cancer cells in vivo, and in vitro. Intravenous doses of ascorbic acid have been found to produce from 25 to 70 times as much plasma concentration as may be attained by oral administration.
The goal of ascorbic acid therapy is the presence of the products of vitamin C in the extracellular fluid. These products of HDIVC were found to kill cancer cells while leaving normal tissue unharmed. A meta-analysis of Vitamin C and cancer apoptosis reviews some of the mechanisms involved.”
“Of the patients in Table 1, studied over the 9 years 2006 to 2014, those with the best outcomes across all stages and types of breast cancer were those who chose to follow all the recommended naturopathic treatments and to not have chemotherapy. This cohort is represented in the last line of that table. The best outcome is considered to be determined by the fewest deaths (5) per number of patients treated in that group (61). That is (61-5)/61 = 92% who survived breast cancer to the point of the study.”
You can read more of their article at:
I want to emphasize that only High Dose Intravenous Vitamin C (IVC) and not oral Vitamin C, has been found to be effective in cancer treatment.
Cancer is an indication that your immune system is compromised. It made sense to me to use a therapy that would assist my immune system to recover instead of damaging it further.
Vitamin C has many immune boosting health benefits. Educate yourself by reading about it on: www.doctoryourself.com . Video’s on Vitamin C are also available on YouTube. I would recommend watching the “The Vitamin Movie”.
I experienced no notable side effects during the treatment and could continue living my normal life.
I am living proof that High Dose Intravenous Vitamin C as a primary breast cancer treatment works, as almost 10 years after being diagnosed I am well and healthy.
It is rare that your orthodox medical doctors would be willing to administer the intravenous high dose vitamin C (IVC). I found an Holistic Integrative Medical Doctor – Dr Herman Spies who was doing IVC at his practice.
The Vitamin C Protocol was one of many alternative protocols I followed in the battle against cancer.
You can read more about the exact protocol I followed in my book “Cancer Healed Naturally“